ACXP fundamentals
The current financial position of Acurx Pharmaceuticals, Inc.
Total assets of ACXP for Q4 24 is 3.86 M USD, 35.52% less than the previous Q3 24. And total liabilities decreased by 2.29% in Q4 24 to 3.24 M USD.
Q1 '20
Q2 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
2.50 M
5.00 M
7.50 M
10.00 M
Total assets
Total liabilities
Currency: USD
Q1 '20
Mar 2020
Q2 '20
Jun 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q4 '21
Dec 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Dec 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Dec 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
Total assetsYoY growth
7.39 M
−34.77%
9.24 M
−0.25%
7.16 M
−34.60%
7.71 M
−17.78%
9.11 M
+23.34%
6.58 M
−28.75%
5.98 M
−16.42%
3.86 M
−49.96%
Total liabilitiesYoY growth
2.07 M
+227.63%
3.02 M
+537.17%
3.22 M
+172.69%
3.04 M
+47.57%
3.11 M
+49.96%
3.15 M
+4.42%
3.32 M
+2.96%
3.24 M
+6.59%
Total equityYoY growth
5.31 M
−50.31%
6.22 M
−29.24%
3.93 M
−59.70%
4.67 M
−36.20%
6.00 M
+12.94%
3.43 M
−44.86%
2.66 M
−32.29%
615.12 K
−86.82%
7.39 M
9.24 M
7.16 M
7.71 M
9.11 M
6.58 M
5.98 M
3.86 M